These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 22078416

  • 1. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.
    Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
    [Abstract] [Full Text] [Related]

  • 2. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F.
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL, Lin WC, Yeh CC, Sun YT.
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.
    Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
    Infantino M, Manfredi M, Grossi V, Benucci M, Morozzi G, Tonutti E, Tampoia M, Bizzaro N.
    Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.
    Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665
    [Abstract] [Full Text] [Related]

  • 13. Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
    Marie I, Hatron PY, Cherin P, Hachulla E, Diot E, Vittecoq O, Menard JF, Jouen F, Dominique S.
    Arthritis Res Ther; 2013 Oct 08; 15(5):R149. PubMed ID: 24286268
    [Abstract] [Full Text] [Related]

  • 14. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group.
    Ann Rheum Dis; 2019 Jul 08; 78(7):988-995. PubMed ID: 31018961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P, André C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C.
    Autoimmun Rev; 2011 Jul 08; 10(9):509-13. PubMed ID: 21447407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug 08; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.